275 related articles for article (PubMed ID: 26915860)
1. Survival Benefit of Early Cancer Detection Through Regular Endoscopic Screening for De Novo Gastric and Colorectal Cancers in Korean Liver Transplant Recipients.
Jung DH; Hwang S; Song GW; Ahn CS; Moon DB; Ha TY; Kim KH; Park GC; Kim BS; Park IJ; Lim SB; Kim JC; Yoo MW; Byeon JS; Jung HY; Lee GH; Myung SJ; Choe J; Choi JY; Park HW; Lee SG
Transplant Proc; 2016; 48(1):145-51. PubMed ID: 26915860
[TBL] [Abstract][Full Text] [Related]
2. De Novo Colorectal and Pancreatic Cancer in Liver-Transplant Recipients: Identifying the Higher-Risk Populations.
Nasser-Ghodsi N; Mara K; Watt KD
Hepatology; 2021 Aug; 74(2):1003-1013. PubMed ID: 33544906
[TBL] [Abstract][Full Text] [Related]
3. Optimal interval of endoscopic screening based on stage distributions of detected gastric cancers.
Hamashima C; Narisawa R; Ogoshi K; Kato T; Fujita K
BMC Cancer; 2017 Nov; 17(1):740. PubMed ID: 29121881
[TBL] [Abstract][Full Text] [Related]
4. De novo malignancies after liver transplantation: incidence comparison with the Korean cancer registry.
Park HW; Hwang S; Ahn CS; Kim KH; Moon DB; Ha TY; Song GW; Jung DH; Park GC; Namgoong JM; Yoon SY; Park CS; Park YH; Lee HJ; Lee SG
Transplant Proc; 2012 Apr; 44(3):802-5. PubMed ID: 22483500
[TBL] [Abstract][Full Text] [Related]
5. De Novo Gastric Cancer After Liver Transplantation.
Gong CS; Yoo MW; Kim BS; Hwang S; Kim KH; Yook JH; Kim BS; Lee SG
Ann Transplant; 2016 Jun; 21():386-91. PubMed ID: 27334929
[TBL] [Abstract][Full Text] [Related]
6. Optimizing repeat liver transplant graft utility through strategic matching of donor and recipient characteristics.
Hung K; Gralla J; Dodge JL; Bambha KM; Dirchwolf M; Rosen HR; Biggins SW
Liver Transpl; 2015 Nov; 21(11):1365-73. PubMed ID: 25865434
[TBL] [Abstract][Full Text] [Related]
7. Risk Factors and Outcomes of De Novo Cancers (Excluding Nonmelanoma Skin Cancer) After Liver Transplantation for Primary Sclerosing Cholangitis.
Mouchli MA; Singh S; Loftus EV; Boardman L; Talwalkar J; Rosen CB; Heimbach JK; Wiesner RH; Hasan B; Poterucha JJ; Kymberly WD
Transplantation; 2017 Aug; 101(8):1859-1866. PubMed ID: 28272287
[TBL] [Abstract][Full Text] [Related]
8. Clinical Significance of De Novo Malignancy After Liver Transplant: A Single-Center Study.
Kim S; Rovgaliyev B; Lee JM; Lee KW; Hong SK; Cho JH; Yoon KC; Yi NJ; Suh KS
Transplant Proc; 2021; 53(1):200-206. PubMed ID: 32409224
[TBL] [Abstract][Full Text] [Related]
9. Posttransplant malignancies in liver transplant recipients.
Akdur A; Kırnap M; Yıldırım S; Altundağ Ö; Moray G; Haberal M
Exp Clin Transplant; 2014 Mar; 12 Suppl 1():162-5. PubMed ID: 24635818
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness outcomes of the national gastric cancer screening program in South Korea.
Cho E; Kang MH; Choi KS; Suh M; Jun JK; Park EC
Asian Pac J Cancer Prev; 2013; 14(4):2533-40. PubMed ID: 23725170
[TBL] [Abstract][Full Text] [Related]
11. Spectrum of De Novo Cancers and Predictors in Liver Transplantation: Analysis of the Scientific Registry of Transplant Recipients Database.
Zhou J; Hu Z; Zhang Q; Li Z; Xiang J; Yan S; Wu J; Zhang M; Zheng S
PLoS One; 2016; 11(5):e0155179. PubMed ID: 27171501
[TBL] [Abstract][Full Text] [Related]
12. Survival after the diagnosis of de novo malignancy in liver transplant recipients.
Taborelli M; Piselli P; Ettorre GM; Baccarani U; Burra P; Lauro A; Galatioto L; Rendina M; Shalaby S; Petrara R; Nudo F; Toti L; Fantola G; Cimaglia C; Agresta A; Vennarecci G; Pinna AD; Gruttadauria S; Risaliti A; Di Leo A; Rossi M; Tisone G; Zamboni F; Serraino D;
Int J Cancer; 2019 Jan; 144(2):232-239. PubMed ID: 30091809
[TBL] [Abstract][Full Text] [Related]
13. National assessment of early hospitalization after liver transplantation: Risk factors and association with patient survival.
Sharma P; Goodrich NP; Schaubel DE; Smith AR; Merion RM
Liver Transpl; 2017 Sep; 23(9):1143-1152. PubMed ID: 28688150
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes of endoscopic submucosal dissection in gastric neoplastic lesions at a single institution in South Korea.
Jang JS; Choi SR; Qureshi W; Kim MC; Kim SJ; Jeung JS; Han SY; Noh MH; Lee JH; Lee SW; Baek YH; Kim SH; Choi PJ
Scand J Gastroenterol; 2009; 44(11):1315-22. PubMed ID: 19891582
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of gastric cancer surveillance in renal transplant recipients.
Lee IS; Kim TH; Kim YH; Yook JH; Kim BS; Han DJ
World J Surg; 2012 Aug; 36(8):1806-10. PubMed ID: 22526049
[TBL] [Abstract][Full Text] [Related]
16. Changing pattern of biliary complications in an evolving liver transplant unit.
Rammohan A; Govil S; Vargese J; Kota V; Reddy MS; Rela M
Liver Transpl; 2017 Apr; 23(4):478-486. PubMed ID: 28152569
[TBL] [Abstract][Full Text] [Related]
17. De novo colorectal cancer: five-year survival is markedly lower in transplant recipients compared with the general population.
Buell JF; Papaconstantinou HT; Skalow B; Hanaway MJ; Alloway RR; Woodle ES
Transplant Proc; 2005 Mar; 37(2):960-1. PubMed ID: 15848590
[TBL] [Abstract][Full Text] [Related]
18. Incidence and long-term risk of de novo malignancies after liver transplantation with implications for prevention and detection.
Schrem H; Kurok M; Kaltenborn A; Vogel A; Walter U; Zachau L; Manns MP; Klempnauer J; Kleine M
Liver Transpl; 2013 Nov; 19(11):1252-61. PubMed ID: 24106037
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of the Korean National Cancer Screening Program in Reducing Gastric Cancer Mortality.
Jun JK; Choi KS; Lee HY; Suh M; Park B; Song SH; Jung KW; Lee CW; Choi IJ; Park EC; Lee D
Gastroenterology; 2017 May; 152(6):1319-1328.e7. PubMed ID: 28147224
[TBL] [Abstract][Full Text] [Related]
20. Is a stricter colonoscopy screening protocol necessary in liver transplant recipients? Comparison with an average-risk population.
Lee HS; Yoo DJ; Park HW; Yang DH; Myung SJ; Yang SK; Lee SG; Byeon JS
Dis Colon Rectum; 2014 Aug; 57(8):976-82. PubMed ID: 25003292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
